{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:21:25Z","timestamp":1778815285086,"version":"3.51.4"},"reference-count":59,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EBPpracticenet","award":["Projet d\u2019impl\u00e9mentation EBPpracticenet 2023"],"award-info":[{"award-number":["Projet d\u2019impl\u00e9mentation EBPpracticenet 2023"]}]},{"name":"Actions de Recherche Concert\u00e9es","award":["DI-PRESCRIBE project; 22\/27-124"],"award-info":[{"award-number":["DI-PRESCRIBE project; 22\/27-124"]}]},{"name":"fond national de recherche scientifique","award":["CDR40013898"],"award-info":[{"award-number":["CDR40013898"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,9,18]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite several calls to deprescribe benzodiazepine receptor agonists (BZRA) in older adults, their use among nursing home residents (NHRs) remains high. Therefore, we developed an intervention targeting general practitioners\u2019 and healthcare professionals\u2019 behaviours regarding BZRA deprescribing in nursing homes (NHs): The END-IT NH (bENzodiazepines Deprescribing InTerventions Nursing homes) 6-component intervention. Before moving on to a large-scale effectiveness and cost-effectiveness evaluation, this feasibility study aims at: (1) assessing the feasibility of the intervention implementation in NHs, (2) assessing the feasibility of conducting a larger-scale evaluation, in terms of recruitment and data collection and (3) conducting an exploratory cost-effectiveness evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will conduct a cluster-randomised controlled trial in a sample of 6 NHs, with 10\u201315 NHRs included per NHs. Four NHs will be randomised into the intervention group, and two NHs will deliver usual care (control group). Data collection will occur at baseline, 3, and 6 months (study end). We will collect information to explore implementation fidelity, mechanisms of impact and contextual factors at patient-level, NH-level and healthcare professional-level, using both quantitative and qualitative measures. The feasibility of the study conduction will be assessed by measuring recruitment and attrition rates and completeness of data collection. An exploratory cost-effectiveness evaluation will be conducted based on quality of life and healthcare use and cost data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study protocol received approval from the ethical committee of CHU UCL Namur on the 20 June 2023. All data are confidential and will be anonymised prior to analysis. De-identified data will be shared on a data depository with a 2-year embargo. The results of the study will be disseminated through a scientific paper and will be communicated to local stakeholders and policymakers through a local symposium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05929443\">NCT05929443<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-085435","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T12:15:32Z","timestamp":1729599332000},"page":"e085435","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Feasibility of a theory-based intervention towards benzodiazepine deprescribing in Belgian nursing homes: protocol of the END-IT NH cluster-randomised controlled trial"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct05929443","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0559-3787","authenticated-orcid":false,"given":"Perrine","family":"Evrard","sequence":"first","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Chevallereau","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6209-137X","authenticated-orcid":false,"given":"Josephine","family":"Aikpitanyi","sequence":"additional","affiliation":[{"name":"Institute of Health and Society (IRSS), UCLouvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7480-0014","authenticated-orcid":false,"given":"Catherine","family":"P\u00e9tein","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Tubeuf","sequence":"additional","affiliation":[{"name":"Institute of Health and Society (IRSS), UCLouvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-8093","authenticated-orcid":false,"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium"},{"name":"Institute of Health and Society (IRSS), UCLouvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium"},{"name":"CHU UCL Namur, Pharmacy department, UCLouvain, Yvoir, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"2025121603105083000_14.10.e085435.1","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1111\/jgs.16751","article-title":"Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study","volume":"68","author":"Evrard","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2025121603105083000_14.10.e085435.2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jamda.2019.06.006","article-title":"Cluster-Controlled Trial of an Intervention to Improve Prescribing in Nursing Homes Study","volume":"20","author":"Strauven","year":"2019","journal-title":"J Am Med Dir Assoc"},{"key":"2025121603105083000_14.10.e085435.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38623.768588.47"},{"key":"2025121603105083000_14.10.e085435.4","doi-asserted-by":"crossref","first-page":"S399","DOI":"10.1016\/S0924-977X(99)00051-6","article-title":"Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?","volume":"9 Suppl 6","author":"Lader","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"2025121603105083000_14.10.e085435.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174730","article-title":"Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis","volume":"12","author":"Donnelly","year":"2017","journal-title":"PLoS One"},{"key":"2025121603105083000_14.10.e085435.6","doi-asserted-by":"publisher","DOI":"10.1159\/000454881"},{"key":"2025121603105083000_14.10.e085435.7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/phar.2170","article-title":"Association between Development of Dementia and Use of Benzodiazepines: A Systematic Review and Meta-Analysis","volume":"38","author":"Lucchetta","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2025121603105083000_14.10.e085435.8","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu145"},{"key":"2025121603105083000_14.10.e085435.9","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-023-00777-y"},{"key":"2025121603105083000_14.10.e085435.10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults","volume":"67","year":"2019","journal-title":"J American Geriatrics Society"},{"key":"2025121603105083000_14.10.e085435.11","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S1041610216001150","article-title":"Psychotropic drug prescriptions in Western European nursing homes","volume":"28","author":"Janus","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"2025121603105083000_14.10.e085435.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.12.021"},{"key":"2025121603105083000_14.10.e085435.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122246","article-title":"What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process","volume":"10","author":"Farrell","year":"2015","journal-title":"PLoS ONE"},{"key":"2025121603105083000_14.10.e085435.14","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00228-014-1725-7","article-title":"Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study","volume":"70","author":"Bourgeois","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"2025121603105083000_14.10.e085435.15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","article-title":"Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework","volume":"17","author":"Evrard","year":"2022","journal-title":"Impl Sci"},{"key":"2025121603105083000_14.10.e085435.16","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11040254","article-title":"The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients-A Systematic Review","volume":"11","author":"Rasmussen","year":"2021","journal-title":"Metabolites"},{"key":"2025121603105083000_14.10.e085435.17","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-018-0544-4"},{"key":"2025121603105083000_14.10.e085435.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2257-8"},{"key":"2025121603105083000_14.10.e085435.19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17512433.2020.1730812","article-title":"A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review","volume":"13","author":"Sawan","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025121603105083000_14.10.e085435.20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s41999-021-00477-5","article-title":"Interventions to optimize medication use in nursing homes: a narrative review","volume":"12","author":"Spinewine","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"2025121603105083000_14.10.e085435.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"},{"key":"2025121603105083000_14.10.e085435.22","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.sapharm.2021.05.018","article-title":"Leveraging implementation science to increase the translation of deprescribing evidence into practice","volume":"18","author":"Ailabouni","year":"2022","journal-title":"Res Soc Admin Pharm"},{"key":"2025121603105083000_14.10.e085435.23","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1111\/jgs.17441","article-title":"Deprescribing and deimplementation: Time for transformative change","volume":"69","author":"Steinman","year":"2021","journal-title":"J American Geriatrics Society"},{"key":"2025121603105083000_14.10.e085435.24","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-38"},{"key":"2025121603105083000_14.10.e085435.25","article-title":"Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups","volume":"9","author":"Evrard","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2025121603105083000_14.10.e085435.26","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-37"},{"key":"2025121603105083000_14.10.e085435.27","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2004.011155"},{"key":"2025121603105083000_14.10.e085435.28","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"key":"2025121603105083000_14.10.e085435.29","doi-asserted-by":"publisher","DOI":"10.1007\/s12160-013-9486-6"},{"key":"2025121603105083000_14.10.e085435.30","unstructured":"The theory and techniques tool. n.d. Available: https:\/\/theoryandtechniquetool.humanbehaviourchange.org"},{"key":"2025121603105083000_14.10.e085435.31","doi-asserted-by":"crossref","first-page":"105053","DOI":"10.1016\/j.jamda.2024.105053","article-title":"Development of a Behavior-Change Intervention toward Benzodiazepine Deprescribing in Older Adults Living in Nursing Homes","volume":"25","author":"Evrard","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"2025121603105083000_14.10.e085435.32","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-016-0065-z","article-title":"Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials","volume":"2","author":"Thabane","year":"2016","journal-title":"Pilot Feasibility Stud"},{"key":"2025121603105083000_14.10.e085435.33","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121603105083000_14.10.e085435.34","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-016-0105-8","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"2","author":"Eldridge","year":"2016","journal-title":"Pilot Feasibility Stud"},{"key":"2025121603105083000_14.10.e085435.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-015959","article-title":"A realist evaluation of patients\u2019 decisions to deprescribe in the EMPOWER trial","volume":"7","author":"Martin","year":"2017","journal-title":"BMJ Open"},{"key":"2025121603105083000_14.10.e085435.36","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025121603105083000_14.10.e085435.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085396","article-title":"Deprescribing benzodiazepine receptor agonists in older adults: a mixed-methods study to adapt the Canadian D-PRESCRIBE intervention to the Belgian community setting","volume":"14","author":"P\u00e9tein","year":"2024","journal-title":"BMJ Open"},{"key":"2025121603105083000_14.10.e085435.38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1258","article-title":"Process evaluation of complex interventions: Medical Research Council guidance","volume":"350","author":"Moore","year":"2015","journal-title":"BMJ"},{"key":"2025121603105083000_14.10.e085435.39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1748-5908-2-40","article-title":"A conceptual framework for implementation fidelity","volume":"2","author":"Carroll","year":"2007","journal-title":"Impl Sci"},{"key":"2025121603105083000_14.10.e085435.40","doi-asserted-by":"publisher","DOI":"10.14524\/CR-16-0003"},{"key":"2025121603105083000_14.10.e085435.41","unstructured":"Drummond MF , Sculpher MJ , Claxton K , et al . Methods for the Economic Evaluation of Health Care Programmes. 4th edn. Oxford University Press, 2015. Available: https:\/\/books.google.co.uk\/books?id=lvWACgAAQBAJ"},{"key":"2025121603105083000_14.10.e085435.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2025121603105083000_14.10.e085435.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2025121603105083000_14.10.e085435.44","unstructured":"Cleemput I , Neyt M , Sande S , et al . Belgian guidelines for economic evaluations and budget impact analyses: second edition. Health Technology Assessment (HTA), KCE report 183c. D\/2012\/10.273\/54. Brussels Belgian Health Care Knowledge Centre (KCE); 2012."},{"key":"2025121603105083000_14.10.e085435.45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s41669-022-00353-3","article-title":"An EQ-5D-5L Value Set for Belgium","volume":"6","author":"Bouckaert","year":"2022","journal-title":"Pharmacoecon Open"},{"key":"2025121603105083000_14.10.e085435.46","first-page":"139","article-title":"Value of Information Analysis for Research Decisions\u2014An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force","volume":"23","author":"Fenwick","year":"2020","journal-title":"V H"},{"key":"2025121603105083000_14.10.e085435.47","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.18","article-title":"The FAIR Guiding Principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Sci Data"},{"key":"2025121603105083000_14.10.e085435.48","unstructured":"Dunham Y . Data repository. OSF; 2015. Available: https:\/\/osf.io\/q5j8g\/"},{"key":"2025121603105083000_14.10.e085435.49","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/ageing\/afab147","article-title":"Barriers and potential solutions in the recruitment and retention of older patients in clinical trials-lessons learned from six large multicentre randomized controlled trials","volume":"50","author":"Buttgereit","year":"2021","journal-title":"Age Ageing"},{"key":"2025121603105083000_14.10.e085435.50","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1111\/jgs.16875","article-title":"Recruitment and Retention of Older People in Clinical Research: A Systematic Literature Review","volume":"68","author":"Forsat","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2025121603105083000_14.10.e085435.51","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07506-7","article-title":"Why do older adults decline participation in research? Results from two deprescribing clinical trials","volume":"24","author":"Strayer","year":"2023","journal-title":"Trials"},{"key":"2025121603105083000_14.10.e085435.52","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-018-0934-9","article-title":"Challenges of conducting research in long-term care facilities: a systematic review","volume":"18","author":"Lam","year":"2018","journal-title":"BMC Geriatr"},{"key":"2025121603105083000_14.10.e085435.53","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-023-04194-5","article-title":"Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework","volume":"23","author":"Thorpe","year":"2023","journal-title":"BMC Geriatr"},{"key":"2025121603105083000_14.10.e085435.54","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-023-01291-5","article-title":"Recommendations for progression criteria during external randomised pilot trial design, conduct, analysis and reporting","volume":"9","author":"Mellor","year":"2023","journal-title":"Pilot Feasibility Stud"},{"key":"2025121603105083000_14.10.e085435.55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CEH.0000000000000193","article-title":"Assessment of Interprofessional Team Collaboration Scale (AITCS): Further Testing and Instrument Revision","volume":"38","author":"Orchard","year":"2018","journal-title":"J Contin Educ Health Prof"},{"key":"2025121603105083000_14.10.e085435.56","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2025121603105083000_14.10.e085435.57","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/34.5.601"},{"key":"2025121603105083000_14.10.e085435.58","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610210001237"},{"key":"2025121603105083000_14.10.e085435.59","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.sapharm.2023.05.010","article-title":"Adaptation and validation of the revised Patients\u2019 Attitudes towards Deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists","volume":"19","author":"P\u00e9tein","year":"2023","journal-title":"Res Soc Admin Pharm"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-085435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:11:05Z","timestamp":1765883465000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-085435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,22]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/bmjopen-2024-085435"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-085435","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}